Insight Molecular Diagnostics Inc. (IMDX) Net margin 2020–2025
Insight Molecular Diagnostics Inc. (IMDX) net profit margin by fiscal year — reported net income divided by reported revenue.
-1.2%FY2025 · since FY2020: -2461.5% → -1.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1.2% | +2.0 pp |
| FY2024 | -3.2% | -1.4 pp |
| FY2023 | -1.8% | +7608.0 pp |
| FY2022 | -7609.8% | -4693.7 pp |
| FY2021 | -2916.2% | -454.6 pp |
| FY2020 | -2461.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice